chrisvoncsefalvay/vaers-outcomes huggingface dataset:
diarrhea; sore throat; lightheadedness; chest discomfort; Shortness of breath; chest pain; Stomach cramps; This spontaneous case was reported by an other health care professional and describes the occurrence of DYSPNOEA (Shortness of breath), CHEST PAIN (chest pain), ABDOMINAL PAIN UPPER (Stomach cramps), DIARRHOEA (diarrhea) and OROPHARYNGEAL PAIN (sore throat) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Pulmonary arterial hypertension. Concomitant products included TREPROSTINIL SODIUM from 13-Jun-2019 to an unknown date for Secondary pulmonary arterial hypertension, SILDENAFIL CITRATE (SILDENAFIL CRISTERS) for an unknown indication.   On 17-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced DYSPNOEA (Shortness of breath), CHEST PAIN (chest pain) and ABDOMINAL PAIN UPPER (Stomach cramps). On an unknown date, the patient experienced DIARRHOEA (diarrhea), OROPHARYNGEAL PAIN (sore throat), DIZZINESS (lightheadedness) and CHEST DISCOMFORT (chest discomfort). At the time of the report, DYSPNOEA (Shortness of breath), CHEST PAIN (chest pain), ABDOMINAL PAIN UPPER (Stomach cramps), DIARRHOEA (diarrhea), OROPHARYNGEAL PAIN (sore throat), DIZZINESS (lightheadedness) and CHEST DISCOMFORT (chest discomfort) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The treatment information was unknown. Action taken with mRNA-1273 in response to the event was not applicable.
2/17/2021-3/7/2021  nighttime shaking, profuse sweating, achiness; daytime chills, shaking, and some sweating
Chills, fever, dizzy, instability 3 weeks headache Limping/pain in left knee-ongoing Burning back pain - on going falling - hitting head - required stitches weakness - ongoing
Started Itching PM on 1/28/21.  Next morning  a tiny bit sore and red.  Four hours later still red but hasn't increased.
Information has been received from a registered nurse (R.N.) concerning a 38-year-old female who on 02-APR-2006 was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). A titer on 03-DEC-2005 was "negative at 6.4 for measles". On 22-FEB-2006 another dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) was administered to the patient. Concomitant vaccination given on that same day included varicella virus vaccine (oka/Merck) (MSD). Another titer was drawn drawn on 28-APR-2006 and again it was negative fro measles at 6.1. Unspecified medical attention was sought. At the time of report the patient's present status was not recovered. No product quality complaint was involved. Additional information has been requested.
REDNESS, SWELLING, TENDERNESS, LOW-GRADE FEVER, and 9x13cm area of induration
Had the vaccines. Had cake that evening. He woke up about 1am-very fussy-until bedtime. Uncontrollable fits. Stopped basic things. Day 7 after vaccine "absent episode" & Day 8.
Tachycardia Site Pain; Cellulitis Narrative:  Site pain and sore arm for 6 days post injection. Second injection 2/1/21: Site pain; fever, chills, headache. Fever 101.4 Day 1 and Day 2 fever 100. Cellulitis at site. Day 3: Treated by Primary Care provider with hot and cold compresses. Day 3: elevated heart rate with shortness of breath. Treated by Primary Care Provider with Atenolol for increased heart rate.  Other Relevant History:
Patient was given Pfizer bivalent vaccine instead of Pfizer monovalent (2nd dose).
4/9/21 at 12:30am -Metallic taste from the bottom of mouth immediate when the injection occurred  -Immediately had pain and heaviness in arm -Immediate motor function impairment. Could not hold a pencil, difficulty operating motor vehicle   4/9/21 at 10am -Sensitivity to light -Brain fog, slow thinking, difficulty with short term memory -Express desire to not communicate with anyone -Felt like I was autistic, couldn?t use the words I needed to express myself -Soreness throughout entire body -Extremely emotional/couldn?t control emotions  4/9/21 at 12:30pm -Impaired motor skills, had a difficult time typing on computer -could not operate motor vehicle due to lack of motor function -extreme brain fog and difficulty with short term memory  -Express desire to not communicate with anyone  4/10/21 -Continued brain fog, slow thinking, difficulty with short term memory -Extremely emotional/couldn?t control emotions -Soreness throughout entire body -lethargy  -Express desire to not communicate with anyone  4/11/21 -Continued brain fog, slow thinking, difficulty with short term memory -Express desire to not communicate with anyone -lethargy -Extremely emotional/couldn?t control emotions  4/12/21  -Extremely emotional/difficulty controlling emotions -lethargy -Continued brain fog, slow thinking, difficulty with short term memory  4/13/21  -Still fatigued and brain fogged.  -Don?t feel like myself.  -Continued brain fog, slow thinking, difficulty with short term memory -Gas and loss of appetite  -Atypical migraine   4/13/21 at 4:30pm -brain fog suddenly lifted, very quickly -Cognitive function restored -all symptoms essentially gone  Felt like my brain reentered my body
pt recvd vax & w/in 24hrs pt exp muscle aches over entire body & fever;pt was seen by a MD & treated w/APAP & advil;pt's muscle aches resolved in 48-72 hrs & fever resolved in 36hrs;
Sickness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sickness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sickness). At the time of the report, ILLNESS (Sickness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information provided. No  treatment information given.
Covid arm. Looks like a sunburn cover large portion of upper arm in a somewhat ?v? shape. Area is hot to the touch. Itches a lot. Also severe joint pain in all joints and bad headache. Joint pain and headache are gone on second day but rash seems to be spreading
Chills then headache and extreme nausea. These all occurred beginning about 10 hours following my first dose of Covid-19 vaccination.
This spontaneous report was received from a medical assistant referring to unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates (reported as from 06-DEC-2016 to 04-JAN-2017), the patients received improperly stored doses of RECOMBIVAX HB lot # M010212, expiration date 21-JAN-2019 (dose and route of administration were not provided) for prophylaxis. There were no adverse events reported. Administered doses of RECOMBIVAX HB were exposed to a temperature excursion of 35°F for 60 hours. Data logger was not involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA007868: US-009507513-1701USA007869: US-009507513-1701USA007870: US-009507513-1701USA007871:
Reported by mother on 7/30/07. States two hours after injection child had rash on anterior and posterior trunk. States no other symptoms - no respiratory distress or swelling. Seen by physician and given shot.
Same day post vax, the pt developed a pink raised rash all over pt's body. No difficulty breathing, face not swollen. Gave Benadryl, rash faded and flat, still pink.
Fever of 100 P.O - 8-9 hours following vaccine. Chills.
Information has been received from a licensed practical nurse concerning an approximately 12 year old patient who on 19-FEB-1997 was vaccinated with a dose of VARIVAX (Merck) (lot #, route and site of administration not reported).  On approximately 13-MAY-2008 the patient developed some vesicle scattered.  At the time of the reporting, the patient's outcome was unknown.  This is one of several reports from the same source.  No further information is available.
Throat is itchy after the vaccine; Really bad headache after the vaccine/temple hurts; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (Throat is itchy after the vaccine) and HEADACHE (Really bad headache after the vaccine/temple hurts) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROAT IRRITATION (Throat is itchy after the vaccine) and HEADACHE (Really bad headache after the vaccine/temple hurts). At the time of the report, THROAT IRRITATION (Throat is itchy after the vaccine) and HEADACHE (Really bad headache after the vaccine/temple hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Therapy non-responder  This case was reported by a nurse and described a subject (age and gender unknown) who did not respond to immunization to hepatitis B vaccine recombinant (Engerix-B).  On unspecified dates, the subject received Energix-B. On an unspecified date before 12 May 2006, a hepatitis B surface antibody titer was negative. It was reported that the titers were taken from one to five months after the third dose of Engerix-B was received.  No adverse events were reported.
A nurse prospectivity reported that a 26-year-old female subject received a dose of hepatitis A inactivated and hepatitis B recombinant vaccine (Twinrix) during the first trimester of pregnancy.  Medical history was notable for no alcohol consumption and no tobacco use. The date of the last menstrual periods was 18 September 2004.  On an unspecified date in either October or November 2004, the mother of the subject received the first dose of Twinrix.  The nurse stated that, she "was four to five weeks pregnant when she received her first dose".  The immunization series with Twinrix was discontinued "until after the pregnancy". On 07 January 2005, at 16 weeks of gestation, the mother of the subject received Amoxicillin trihydrate + potassium clavulanate (Augmentin) and Phenergan with codeine to treat sinusitis.  ON 16 February 2005, at 21 weeks of gestation, the mother of the subject again received Augmentin to treat sinusitis.  The subject was born via cesarean section after a 40 week gestation.  The subject is a male and weighted 4.1 kg and was 21 inches in length.  No birth defects were noted .  Postnatally, on 29 June 2005, the subject was noted to be jaundiced.  The outcome of the jaundice was not reported.  Comment: Jaundice was assessed as medically serious.  (OMIC)
Developed substernal chest pressure 10 minutes after her vaccination. Resolved on its own without intervention.
Large golfball size welt within 2-3 min. of injection at the injection site
3 1/2 cm x 5 cm swelling and redness to RPUA.
Site was red, warm with a large knot under the skin which is still present. Low grade fever for a couple of days, itching, painful for 7-10 days.
Patient with 2 Moderna COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "83 y/o Female with a past medical history of HTN, nicotine dependence, HLD, CKD 3 and anxiety.  She developed LLQ abdominal pain and was found to have an apple core lesion by CT with uterine fundus infiltration in the ED.  Colonoscopy was completed 8/25/2022 by Dr. with pathology report showing adenoma with high-grade dysplasia with final diagnosis of metastatic mucinous adenocarcinoma.   Referral for sigmoid colectomy was made however the patient returned to the ED 8/27/2022 due to worsening abdominal pain, generalized weakness, poor PO intake and constipation.  The patient underwent exploratory laparotomy with small bowel resection and loop transverse colostomy.     When medically stable, the patient was discharged to Local Health facility for  acute inpatient rehabilitation of functional and cognitive deficits.  The patient was transferred with supplemental oxygen, which was continued to maintain the patient's saturations above 92%.  The patient did not report dyspnea but was noted to become hypoxic with exertion and when sleeping.     Symptoms related to these abovementioned conditions and events were well-controlled, and the patient was discharged medically stable and improved. There were no significant acute episodes that affected length of stay or tolerance to therapies. The patient was provided education regarding colostomy care.  At first she was reluctant however was able to follow instructions provided by nursing by the time of discharge."
Subsequent to receiving vax, the pt developed hypotonia, lethargy and poor oral intake. The pt also became expressionless.
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 21-SEP-2015, the patient was vaccinated with RECOMBIVAX HB (first dose) (route, lot # and expiration date were not reported). On 29-NOV-2015 and 23-JAN-2016 the patient received the second and the third dose of RECOMBIVAX HB respectively (inappropriate schedule of drug administration). No adverse effect reported. At the time of the report, the outcome of the event was unknown. Additional information has been requested.
DTaP site is red, warm and has a hard area approximately 2 cm x 3cm. Hib site is red without warmth. Prevnar site has no signs of reaction.
Information has been received from a physician concerning a female who was vaccinated in the arm with the first dose of Gardasil. It was reported that the patient experienced injection site pain after receiving the first dose. At the time of the report, it was unknown if the patient recovered. Additional information has been requested.
20 hrs after injection, I started sweating, felt very nauseated, chills and headache. It only lasted 5 minutes
Early morning after second dose: severe pain in left side of neck progressing up to forehead causing severe headache, dry hacking cough, difficulty breathing. Saw PCP, Dr that day and was prescribed steroids to assist with breathing and cough syrup. Next day same side effects but meds helping, nervous energy. Note: had nervous energy after first dose on first few days as well. April 10, 2021, four days after second dose: phlegm building up in head and chest, coughing with little phlegm, so thick it causes choking with eyes and nose running, leading to loss of breath and almost loss of consciousness, severe headaches, continued neck pain with swelling appears to have radiated from left arm injection site, continued difficulty breathing, severe nausea and stomach cramping, body aches especially in legs, hot flashes mixed with chills (back and forth.) No fever, however. Contacted PCP. As of April 16, 2021, side effects continue with weakness in limbs, extreme lethargy and sleepiness, but restless sleep that's interupted by coughing/choking.
she experienced bruising and a rash at the injection site that spread down her entire arm.; she experienced bruising and a rash at the injection site that spread down her entire arm.; This spontaneous report was received from a company representative referring to a 11 years old female patient. Information about medical history, concurrent condition and concomitant therapy was not provided.  On 21-MAR-2022, after receiving her 2nd dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, frequency, route, lot # and expiration date were not reported) for prophylaxis, the patient experienced bruising and a rash at the injection site that spread down her entire arm. It was also reported that the patient went to the emergency room for "lab testing" but it was unknown if she was admitted to the hospital. The patient received acetaminophen (TYLENOL) as treatment. The outcome of the events was reported as recovering. The causality of the events was not reported.
3/28/21 Burning sensation soles of both feet, pins & needles feeling throughout body. Weakness arms and legs. Still continuing not as intense. Had GBS 40+ years ago Treatment has been acupunture, aleve & tylenol 2x daily
prolific pain and swelling of both hands- resembles RS3PE ( remitting seronegative symmetrical synovitis with pitting edema ) responsive to oral steroids
Information has been received from a pharmacy technician referring to a 15 year old patient of unknown gender. The patient's pertinent medical history, concomitant medication and drug reactions/allergies were not provided. In approximately October 2018 (reported as "about a month ago"), the patient was vaccinated with PROQUAD (strength, dose, lot #, expiration date were not reported) for prophylaxis (product administered to patient of inappropriate age). The vaccine was reconstituted with sterile diluent (lot # and expiration date were unknown by reporter). No adverse effects were reported.
9JUL91 w/in 1hr of immun was taken to ER; had fever of 104; No cause for fever was identified;
doses were given after expiration date; Vaccine placed in refrigerator on 29 Oct 2021 ,vaccine expired on 13 Oct 2021,vaccine administered on 3 Nov 2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine placed in refrigerator on 29 Oct 2021 ,vaccine expired on 13 Oct 2021,vaccine administered on 3 Nov 2021) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine placed in refrigerator on 29 Oct 2021 ,vaccine expired on 13 Oct 2021,vaccine administered on 3 Nov 2021). On 03-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine placed in refrigerator on 29 Oct 2021 ,vaccine expired on 13 Oct 2021,vaccine administered on 3 Nov 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided It was mentioned that the vial was initially refrigerated  on 29 Oct 2021, the vial did not undergo any temperature excursion and the patient did not experienced any adverse events. Treatment medication was not provided by the reporter
Information has been received from a nurse practitioner concerning a female (age not reported) who on an unspecified date was vaccinated with Gardasil vaccine (yeast). Subsequently, the patient developed "total body itching" (date unknown). At the time of this report, the outcome of the event was unknown. Additional information has been requested.
About 24 hours after the vaccine, my symptoms became much worse. My fever spiked to 103.3 and I had a severe headache, nausea, and muscle stiffness. My lips also swelled and chapped.  After another 24 hours passed, I developed a rash on the lower part of my neck which has spread downward and covered the rest of my body now. As well, my tongue has become very sensitive and sore and has red streaks and tiny white bumps towards the back. After my first dose, I did have a higher fever and headache but not nearly as bad as the second time. I did have COVID in December 2020 but only had a fever of 101-102 and fatigue for a couple of days.
Information has been received from a consumer concerning a female physician who was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (Lot#644218/1027M). Subsequently the physician developed a rash. The reporter has no other information to provide. Unspecified medical attention was sought. Follow up information from the patient indicated that following vaccination the physician developed pain and swelling in her deltoid and shoulder area. She reported that she could not lie down on that side and that she could not lift her arm because of the pain. The physician stated that it was not cellulitis, and she was treated with an anti inflammatory and ice packs. Two other patients developed a rash after being vaccinated with a dose of pneumococcal vaccine 23 polyvalent (lot# 644218/1027M) (WAES0302USA02882 and WAES0303USA01561). Additional information has been requested.
Shortness of breath at rest, chest tightness, coughing with deep breathing: approx. 48 hours after the vaccination Otherwise, normal flu-like symptoms between 12 to 24 hours: - pounding headache - night sweats - feverish - muscle aches - fatigue
Left and Right arm extremly sore after 4 months. Difficulty lifting and using arm. Difficulty to sleep on left and right side of body due to shoulder pain at injection site.
Patient was given the Pfizer covid-19 vaccine in his left arm. He switched seats and I gave him his flu vaccine in his right arm. He started bleeding so I removed the bandage and held pressure with a cotton ball. The bleeding stopped and there was a welt and the patient started to feel lightheaded and like he was going to black out. Patient appeared pale and out of it. Called 911 and patient put head between knees and drank water. Laid on the floor with feet elevated. Vital signs assessed. Patient reported vision better but echoing still in ears mildly. Condition improved before arrival of EMS.